805
Views
0
CrossRef citations to date
0
Altmetric
Cognition

Validity and reliability measures of the Swedish Karolinska version of the Edinburgh Cognitive and Behavioral ALS Screen (SK-ECAS)

ORCID Icon, , , , , , , & ORCID Icon show all
Pages 713-718 | Received 11 Apr 2023, Accepted 15 Jul 2023, Published online: 31 Jul 2023

References

  • del Aguila MA, Longstreth WT, Jr, McGuire V, Koepsell TD, van Belle G. Prognosis in amyotrophic lateral sclerosis: a population-based study. Neurology 2003;60:813–9. PMID: 12629239.
  • Cengiz B, Fidancı H, Baltacı H, Türksoy E, Kuruoğlu R. Reduced occipital cortex excitability in amyotrophic lateral sclerosis. J Clin Neurophysiol. 2022;39:486–91.
  • Hanstock C, Sun K, Choi C, Eurich D, Camicioli R, Johnston W, et al. Spectroscopic markers of neurodegeneration in the mesial prefrontal cortex predict survival in ALS. Amyotroph Lateral Scler Frontotemporal Degener. 2020;21:246–51.
  • van Es MA, Hardiman O, Chio A, Al-Chalabi A, Pasterkamp RJ, Veldink JH, et al. Amyotrophic lateral sclerosis. Lancet. 2017;390:2084–98.
  • Chì A, Moglia C, Canosa A, Manera U, Vasta R, Brunetti M, et al. Cognitive impairment across ALS clinical stages in a population-based cohort. Amyotroph Lateral Scler Frontotemporal Degener. 2023;1–6.
  • Nasreddine ZS, Phillips NA, Bédirian V, Charbonneau S, Whitehead V, Collin I, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53:695–9.
  • Aiello EN, Solca F, Torre S, Carelli L, Ferrucci R, Priori A, et al. Diagnostics and clinical usability of the Montreal Cognitive Assessment (MoCA) in amyotrophic lateral sclerosis. Front Psychol. 2022;13:1012632.
  • Gosselt IK, Nijboer TCW, Es MA, Van, Van Es MA. An overview of screening instruments for cognition and behavior in patients with ALS: selecting the appropriate tool for clinical practice. Amyotroph Lateral Scler Frontotemporal Degener. 2020;21:324–36.
  • Abrahams S, Newton J, Niven E, Foley J, Thomas H, Abrahams S, et al. Screening for cognition and behaviour changes in ALS. Amyotroph Lateral Scler Frontotemporal Degener. 2014;15:9–14.
  • Crockford CJ, Kleynhans M, Wilton E, Radakovic R, Newton J, Niven EH, et al. ECAS A-B-C: alternate forms of the Edinburgh Cognitive and Behavioural ALS screen. Amyotroph Lateral Scler Frontotemporal Degener. 2018;19:57–64.
  • Forsberg KM, Graffmo KS, Stenvall E, Tabikh N, Marklund SL, Brännström T, et al. Widespread CNS pathology in amyotrophic lateral sclerosis homozygous for the D90A SOD1 mutation. Acta Neuropathol. 2023;145:13–28. Epub 2022 Nov 16. PMID: 36385230
  • Finsel J, Winroth I, Ciećwierska K, Helczyk O, Stenberg EA, Häggström A-C, et al. Determining impairment in the Swedish, Polish and German ECAS: the importance of adjusting for age and education. Amyotroph Lateral Scler Frontotemporal Degener. 2023;24:475–84. PMID: 36994762
  • Longinetti E, Regodón Wallin A, Samuelsson K, Press R, Zachau A, Ronnevi L-O, et al. The Swedish motor neuron disease quality registry. Amyotroph Lateral Scler Frontotemporal Degener. 2018;19:528–37.
  • Niven E, Newton J, Foley J, Colville S, Swingler R, Chandran S, et al. Validation of the Edinburgh Cognitive and Behavioural Amyotrophic Lateral Sclerosis Screen (ECAS): a cognitive tool for motor disorders. Amyotroph Lateral Scler Frontotemporal Degener. 2015;16:172–9.
  • Cronbach LJ. Coefficient alpha and the internal structure of tests. Psychometrika 1951;16:297–334.
  • Hodgins F, Mulhern S, Abrahams S. The clinical impact of the Edinburgh Cognitive and Behavioural ALS Screen (ECAS) and neuropsychological intervention in routine ALS care. Amyotroph Lateral Scler Frontotemporal Degener. 2020;21:92–9. Epub 2019 Oct 15. PMID: 31612737.
  • Mojtabavi H, Nafissi S, Mahmoodi-Bakhtiari B, Fathi D, Fatehi F. Persian adaptation of Edinburgh Cognitive and Behavioural Screen (ECAS). Amyotroph Lateral Scler Frontotemporal Degener. 2021;22:426–33.
  • Mora J, Salas T, Camino Fernández M, Rodríguez-Castillo V, Marín S, Chaverri D, et al. Spanish adaptation of the Edinburgh cognitive and behavioral amyotrophic lateral sclerosis screen (ECAS). Amyotroph Lateral Scler Frontotemporal Degener. 2018;19:74–9.
  • Ye S, Ji Y, Li C, He J, Liu X, Fan D. The Edinburgh Cognitive and Behavioural ALS screen in a chinese amyotrophic lateral sclerosis population. PLoS One. 2016;11:e0155496. PMID: 27195772; PMCID: PMC4873026.
  • Watanabe Y, Ogino M, Ichikawa H, Hanajima R, Nakashima K. The Edinburgh Cognitive and Behavioural ALS Screen (ECAS) for Japanese ALS and FTD patients. Amyotroph Lateral Scler Frontotemporal Degener. 2021;22:66–72. Epub 2020 Aug 6. PMID: 32757854.
  • Poletti B, Solca F, Carelli L, Madotto F, Lafronza A, Faini A, et al. The validation of the Italian Edinburgh Cognitive and Behavioural ALS Screen (ECAS). Amyotroph Lateral Scler Frontotemporal Degener. 2016;17:489–98. Epub 2016 May 24. PMID: 27219526.